A Comparison of Two Dose Levels of Didanosine Used in Combination With Stavudine in HIV-Infected Patients
- Conditions
- HIV Infections
- Registration Number
- NCT00002207
- Lead Sponsor
- Bristol-Myers Squibb
- Brief Summary
The purpose of this study is to compare the effectiveness of taking didanosine (ddI) once a day plus stavudine (d4T) twice a day with taking ddI twice a day plus d4T twice a day. This study also examines the safety of giving ddI with d4T in the short-term.
- Detailed Description
Patients are randomized to receive ddI given either qd or bid in combination with d4T given bid (no doses specified).
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (13)
ID Care Inc
🇺🇸Somerville, New Jersey, United States
Fanno Creek Clinic
🇺🇸Portland, Oregon, United States
Dr Iraj Mirshahi
🇺🇸Richmond, Virginia, United States
Clinsites / Sorra Research Ctr
🇺🇸Birmingham, Alabama, United States
Indiana Univ School of Medicine / Dept of Infect Dis
🇺🇸Indianapolis, Indiana, United States
New Jersey Community Research Initiative
🇺🇸Newark, New Jersey, United States
Anderson Clinical Research
🇺🇸Pittsburgh, Pennsylvania, United States
Univ of Texas Southwestern Med Ctr of Dallas
🇺🇸Dallas, Texas, United States
Univ of Texas Med Branch
🇺🇸Galveston, Texas, United States
Houston Clinical Research Network
🇺🇸Houston, Texas, United States
Shared Med Research Foundation
🇺🇸Tarzana, California, United States
Hampton Roads Med Specialists
🇺🇸Hampton, Virginia, United States
Medicine Faculty Associates
🇺🇸Ypsilanti, Michigan, United States